270 related articles for article (PubMed ID: 24999622)
1. Low concentration of quercetin antagonizes the cytotoxic effects of anti-neoplastic drugs in ovarian cancer.
Li N; Sun C; Zhou B; Xing H; Ma D; Chen G; Weng D
PLoS One; 2014; 9(7):e100314. PubMed ID: 24999622
[TBL] [Abstract][Full Text] [Related]
2. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
Yang YI; Kim JH; Lee KT; Choi JH
Gynecol Oncol; 2011 Dec; 123(3):588-96. PubMed ID: 21945308
[TBL] [Abstract][Full Text] [Related]
3. Ursolic acid inhibits the proliferation of human ovarian cancer stem-like cells through epithelial-mesenchymal transition.
Zhang J; Wang W; Qian L; Zhang Q; Lai D; Qi C
Oncol Rep; 2015 Nov; 34(5):2375-84. PubMed ID: 26323892
[TBL] [Abstract][Full Text] [Related]
4. Brown algae phlorotannins enhance the tumoricidal effect of cisplatin and ameliorate cisplatin nephrotoxicity.
Yang YI; Ahn JH; Choi YS; Choi JH
Gynecol Oncol; 2015 Feb; 136(2):355-64. PubMed ID: 25462204
[TBL] [Abstract][Full Text] [Related]
5. Clarithromycin synergizes with cisplatin to inhibit ovarian cancer growth in vitro and in vivo.
Zhou B; Xia M; Wang B; Thapa N; Gan L; Sun C; Guo E; Huang J; Lu Y; Cai H
J Ovarian Res; 2019 Nov; 12(1):107. PubMed ID: 31703731
[TBL] [Abstract][Full Text] [Related]
6. Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways.
Shen W; Liang B; Yin J; Li X; Cheng J
Cell Biochem Biophys; 2015 May; 72(1):203-13. PubMed ID: 25510462
[TBL] [Abstract][Full Text] [Related]
7. CYT-Rx20 inhibits ovarian cancer cells in vitro and in vivo through oxidative stress-induced DNA damage and cell apoptosis.
Wang YY; Chen YK; Hu SC; Hsu YL; Tsai CH; Chi TC; Huang WL; Hsieh PW; Yuan SF
Cancer Chemother Pharmacol; 2017 Jun; 79(6):1129-1140. PubMed ID: 28500555
[TBL] [Abstract][Full Text] [Related]
8. Novel expression of CD11b in epithelial ovarian cancer: Potential therapeutic target.
Saed GM; Fletcher NM; Diamond MP; Morris RT; Gomez-Lopez N; Memaj I
Gynecol Oncol; 2018 Mar; 148(3):567-575. PubMed ID: 29329880
[TBL] [Abstract][Full Text] [Related]
9. JS-K, a nitric oxide donor, induces autophagy as a complementary mechanism inhibiting ovarian cancer.
Liu B; Huang X; Li Y; Liao W; Li M; Liu Y; He R; Feng D; Zhu R; Kurihara H
BMC Cancer; 2019 Jul; 19(1):645. PubMed ID: 31262254
[TBL] [Abstract][Full Text] [Related]
10. Bithionol inhibits ovarian cancer cell growth in vitro - studies on mechanism(s) of action.
Ayyagari VN; Brard L
BMC Cancer; 2014 Feb; 14():61. PubMed ID: 24495391
[TBL] [Abstract][Full Text] [Related]
11. Quercetin induces endoplasmic reticulum stress to enhance cDDP cytotoxicity in ovarian cancer: involvement of STAT3 signaling.
Yang Z; Liu Y; Liao J; Gong C; Sun C; Zhou X; Wei X; Zhang T; Gao Q; Ma D; Chen G
FEBS J; 2015 Mar; 282(6):1111-25. PubMed ID: 25611565
[TBL] [Abstract][Full Text] [Related]
12. The Akt inhibitor MK-2206 enhances the cytotoxicity of paclitaxel (Taxol) and cisplatin in ovarian cancer cells.
Lin YH; Chen BY; Lai WT; Wu SF; Guh JH; Cheng AL; Hsu LC
Naunyn Schmiedebergs Arch Pharmacol; 2015 Jan; 388(1):19-31. PubMed ID: 25164962
[TBL] [Abstract][Full Text] [Related]
13. Anemoside B4 attenuates nephrotoxicity of cisplatin without reducing anti-tumor activity of cisplatin.
He L; Zhang Y; Kang N; Wang Y; Zhang Z; Zha Z; Yang S; Xu Q; Liu Y
Phytomedicine; 2019 Mar; 56():136-146. PubMed ID: 30668334
[TBL] [Abstract][Full Text] [Related]
14. Dihydrodiol dehydrogenases regulate the generation of reactive oxygen species and the development of cisplatin resistance in human ovarian carcinoma cells.
Chen J; Adikari M; Pallai R; Parekh HK; Simpkins H
Cancer Chemother Pharmacol; 2008 May; 61(6):979-87. PubMed ID: 17661040
[TBL] [Abstract][Full Text] [Related]
15. Quercetin enhances apoptotic effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in ovarian cancer cells through reactive oxygen species (ROS) mediated CCAAT enhancer-binding protein homologous protein (CHOP)-death receptor 5 pathway.
Yi L; Zongyuan Y; Cheng G; Lingyun Z; Guilian Y; Wei G
Cancer Sci; 2014 May; 105(5):520-7. PubMed ID: 24612139
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathways in the chemosensitization of cisplatin by quercetin in human head and neck cancer.
Sharma H; Sen S; Singh N
Cancer Biol Ther; 2005 Sep; 4(9):949-55. PubMed ID: 16082193
[TBL] [Abstract][Full Text] [Related]
17. RIP1 promotes proliferation through G2/M checkpoint progression and mediates cisplatin-induced apoptosis and necroptosis in human ovarian cancer cells.
Zheng XL; Yang JJ; Wang YY; Li Q; Song YP; Su M; Li JK; Zhang L; Li ZP; Zhou B; Lin Y
Acta Pharmacol Sin; 2020 Sep; 41(9):1223-1233. PubMed ID: 32242118
[TBL] [Abstract][Full Text] [Related]
18. Wnt/β-catenin agonist BIO alleviates cisplatin-induced nephrotoxicity without compromising its efficacy of anti-proliferation in ovarian cancer.
Sun Z; Xu S; Cai Q; Zhou W; Jiao X; Bao M; Yu X
Life Sci; 2020 Dec; 263():118672. PubMed ID: 33121990
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of anti-tumor effects of 5-fluorouracil on hepatocellular carcinoma by low-intensity ultrasound.
Hu Z; Lv G; Li Y; Li E; Li H; Zhou Q; Yang B; Cao W
J Exp Clin Cancer Res; 2016 Apr; 35():71. PubMed ID: 27102814
[TBL] [Abstract][Full Text] [Related]
20. Cell-cycle inhibition and apoptosis induced by curcumin and cisplatin or oxaliplatin in human ovarian carcinoma cells.
Montopoli M; Ragazzi E; Froldi G; Caparrotta L
Cell Prolif; 2009 Apr; 42(2):195-206. PubMed ID: 19236381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
